Pharmazell Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CHOLIC ACID, with a corresponding US DMF Number 41790.
Remarkably, this DMF maintains an Active status since its submission on May 23, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 20, 2025, and payment made on May 01, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II